Latest stories on SGMOQ
SANGAMO THERAPEUTICS, INC (SGMOQ) files 8-K
SEC 8-K50 · neutralgeneral
SANGAMO THERAPEUTICS, INC (SGMOQ) files 8-K
SEC 8-K50 · neutralgeneral
Sangamo Therapeutics Launches Auction Process for Clinical-Stage Chronic Neuropathic Pain Program
GlobeNewswire58 · neutralm&a
Fabry Disease Market Outlook: 6 Upcoming Therapies Set to Influence the Future Market Landscape | DelveInsight
PR Newswire50 · neutralgeneral
PTC Completes Acquisition of ST-920 Fabry Disease Gene Therapy
PR Newswire62 · neutralm&a
SANGAMO THERAPEUTICS, INC (SGMOQ) files 8-K
SEC 8-K22 · bearishgeneral
Nasdaq says to delist Nuvve Holding, Maxeon Solar, Sangamo
The Fly32 · bearishgeneral
SANGAMO THERAPEUTICS, INC (SGMOQ) files 8-K
SEC 8-K22 · bearishgeneral
SANGAMO THERAPEUTICS, INC (SGMOQ) files 8-K
SEC 8-K50 · neutralgeneral
Sangamo Therapeutics Delays Quarterly 10-Q Filing
TipRanks34 · bearishgeneral
SANGAMO THERAPEUTICS, INC (SGMOQ) files 8-K
SEC 8-K50 · neutralgeneral
Sangamo Therapeutics Advances Bankruptcy Asset Sale Process
TipRanks22 · bearishgeneral
SANGAMO THERAPEUTICS, INC (SGMOQ) files 8-K
SEC 8-K22 · bearishgeneral
SANGAMO THERAPEUTICS, INC (SGMOQ) files 8-K
SEC 8-K50 · neutralgeneral
Sangamo Therapeutics, Inc. 2026 Q1 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings